Cargando…

Global Mental Health and Pharmacology: The Case of Attention Deficit and Hyperactivity Disorders in Brazil

Global Mental Health (GMH) is the field of study, research, and intervention, which aims at improving access to mental health worldwide. It is based on the global burden of disease research program and on the existence of a large “treatment gap” between the need and availability of mental health ser...

Descripción completa

Detalles Bibliográficos
Autores principales: Ortega, Francisco, Müller, Manuela Rodrigues
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022440/
https://www.ncbi.nlm.nih.gov/pubmed/33869481
http://dx.doi.org/10.3389/fsoc.2020.535125
_version_ 1783674927656730624
author Ortega, Francisco
Müller, Manuela Rodrigues
author_facet Ortega, Francisco
Müller, Manuela Rodrigues
author_sort Ortega, Francisco
collection PubMed
description Global Mental Health (GMH) is the field of study, research, and intervention, which aims at improving access to mental health worldwide. It is based on the global burden of disease research program and on the existence of a large “treatment gap” between the need and availability of mental health services, displaying individual and social costs of undiagnosed and untreated mental disorders, especially in low- and middle-income countries (LMIC). Few academic publications in Brazil dialogue directly with the field of GMH, although several issues drawn from its agenda have been the subject of mental health policies in the country. Brazil can be classified as a middle-income country with a well-structured national health system. This system is oriented toward primary health care, which integrates both community mental health services and the broader health care network. The debate between GMH advocates and critics has unearthed old controversies in psychiatry such as universality or cultural specificity of mental disorders, their expressions, and their relationship with social and economic factors. We intend to examine how these controversies reverberate in the Brazilian mental health scenario, taking as an illustration the debates around Attention Deficit Hyperactivity Disorder (ADHD) in the country. ADHD discussions oppose those who argue that the condition is underdiagnosed and undertreated, and those who claim that there is overdiagnosis and overtreatment and thus, medicalization of childhood. This article presents the current status of the Brazilian mental health literature on ADHD, with emphasis on tensions around diagnosis, prevalence and interventions. Our aim is to highlight how the differential in discourse shapes the debate on ADHD in Brazil and how this may contribute to the GMH agenda. This goal will be undertaken in three steps. First, we will briefly examine studies around GMH and ADHD. Secondly, we address Brazilian studies on this theme, considering the specificities regarding the constitution of the mental health field. Finally, we will examine the debate of treatment gap vs. medicalization in the country in order to underscore the potentials and limitations of each perspective.
format Online
Article
Text
id pubmed-8022440
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80224402021-04-15 Global Mental Health and Pharmacology: The Case of Attention Deficit and Hyperactivity Disorders in Brazil Ortega, Francisco Müller, Manuela Rodrigues Front Sociol Sociology Global Mental Health (GMH) is the field of study, research, and intervention, which aims at improving access to mental health worldwide. It is based on the global burden of disease research program and on the existence of a large “treatment gap” between the need and availability of mental health services, displaying individual and social costs of undiagnosed and untreated mental disorders, especially in low- and middle-income countries (LMIC). Few academic publications in Brazil dialogue directly with the field of GMH, although several issues drawn from its agenda have been the subject of mental health policies in the country. Brazil can be classified as a middle-income country with a well-structured national health system. This system is oriented toward primary health care, which integrates both community mental health services and the broader health care network. The debate between GMH advocates and critics has unearthed old controversies in psychiatry such as universality or cultural specificity of mental disorders, their expressions, and their relationship with social and economic factors. We intend to examine how these controversies reverberate in the Brazilian mental health scenario, taking as an illustration the debates around Attention Deficit Hyperactivity Disorder (ADHD) in the country. ADHD discussions oppose those who argue that the condition is underdiagnosed and undertreated, and those who claim that there is overdiagnosis and overtreatment and thus, medicalization of childhood. This article presents the current status of the Brazilian mental health literature on ADHD, with emphasis on tensions around diagnosis, prevalence and interventions. Our aim is to highlight how the differential in discourse shapes the debate on ADHD in Brazil and how this may contribute to the GMH agenda. This goal will be undertaken in three steps. First, we will briefly examine studies around GMH and ADHD. Secondly, we address Brazilian studies on this theme, considering the specificities regarding the constitution of the mental health field. Finally, we will examine the debate of treatment gap vs. medicalization in the country in order to underscore the potentials and limitations of each perspective. Frontiers Media S.A. 2020-09-29 /pmc/articles/PMC8022440/ /pubmed/33869481 http://dx.doi.org/10.3389/fsoc.2020.535125 Text en Copyright © 2020 Ortega and Müller. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Sociology
Ortega, Francisco
Müller, Manuela Rodrigues
Global Mental Health and Pharmacology: The Case of Attention Deficit and Hyperactivity Disorders in Brazil
title Global Mental Health and Pharmacology: The Case of Attention Deficit and Hyperactivity Disorders in Brazil
title_full Global Mental Health and Pharmacology: The Case of Attention Deficit and Hyperactivity Disorders in Brazil
title_fullStr Global Mental Health and Pharmacology: The Case of Attention Deficit and Hyperactivity Disorders in Brazil
title_full_unstemmed Global Mental Health and Pharmacology: The Case of Attention Deficit and Hyperactivity Disorders in Brazil
title_short Global Mental Health and Pharmacology: The Case of Attention Deficit and Hyperactivity Disorders in Brazil
title_sort global mental health and pharmacology: the case of attention deficit and hyperactivity disorders in brazil
topic Sociology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022440/
https://www.ncbi.nlm.nih.gov/pubmed/33869481
http://dx.doi.org/10.3389/fsoc.2020.535125
work_keys_str_mv AT ortegafrancisco globalmentalhealthandpharmacologythecaseofattentiondeficitandhyperactivitydisordersinbrazil
AT mullermanuelarodrigues globalmentalhealthandpharmacologythecaseofattentiondeficitandhyperactivitydisordersinbrazil